Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.325
-0.075 (-5.36%)
Aug 14, 2025, 11:56 AM - Market open
Heron Therapeutics Employees
Heron Therapeutics had 122 employees as of December 31, 2024. The number of employees decreased by 4 or -3.17% compared to the previous year.
Employees
122
Change (1Y)
-4
Growth (1Y)
-3.17%
Revenue / Employee
$1,227,000
Profits / Employee
-$7,631
Market Cap
203.11M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 122 | -4 | -3.17% |
Dec 31, 2023 | 126 | -77 | -37.93% |
Dec 31, 2022 | 203 | -99 | -32.78% |
Dec 31, 2021 | 302 | 79 | 35.43% |
Dec 31, 2020 | 223 | -8 | -3.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
HRTX News
- 5 days ago - Heron Therapeutics, Inc. (HRTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress - PRNewsWire
- 6 days ago - Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile - PRNewsWire
- 6 days ago - Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025 - PRNewsWire
- 16 days ago - Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025 - PRNewsWire
- 3 months ago - Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025 - Seeking Alpha
- 3 months ago - Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates - PRNewsWire